Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors

Academic Article

Abstract

  • The HIV-1 protein Tat is a critical regulator of viral transcription and has also been implicated as a mediator of HIV-1 induced neurotoxicity. Here using a high throughput screening assay, we identified the GSK-3 inhibitor 6BIO, as a Tat-dependent HIV-1 transcriptional inhibitor. Its ability to inhibit HIV-1 transcription was confirmed in TZM-bl cells, with an IC50 of 40nM. Through screening 6BIO derivatives, we identified 6BIOder, which has a lower IC50 of 4nM in primary macrophages and 0.5nM in astrocytes infected with HIV-1. 6BIOder displayed an IC50 value of 0.03nM through in vitro GSK-3β kinase inhibition assays. Finally, we demonstrated 6BIO and 6BIOder have neuroprotective effects on Tat induced cell death in rat mixed hippocampal cultures. Therefore 6BIO and its derivatives are unique compounds which, due to their complex mechanisms of action, are able to inhibit HIV-1 transcription as well as to protect against Tat induced neurotoxicity. © 2011 Elsevier Inc.
  • Authors

    Published In

  • Virology  Journal
  • Digital Object Identifier (doi)

    Pubmed Id

  • 23950893
  • Author List

  • Kehn-Hall K; Guendel I; Carpio L; Skaltsounis L; Meijer L; Al-Harthi L; Steiner JP; Nath A; Kutsch O; Kashanchi F
  • Start Page

  • 56
  • End Page

  • 68
  • Volume

  • 415
  • Issue

  • 1